PhosPrint is a laser bioprinter developer focusing on the highly precise and rapid delivery of cells and other bio-inks on the substrates of interest for tissue regeneration and biosensor applications.
Meet PhosDB I
A high-resolution, user-friendly laser bioprinter
for demanding cell-printing applications
events | press releases | media coverage
We are very proud to announce the launch of the EU funded project "Tumor-LN-oC" (Tumor and Lymph Node on Chip for cancer studies).
We are proud to announce the start of our collaboration with the Patras Science Park under the Proof of Concept program.
Ioanna Zergioti, Co-Founder and CTO presents Phosprint during the
webinar "Women in the Greek Entrepreneurial Ecosystem" on 11/11/2020
organized by the global initiative Weekly Women Entrepreneurship 2020.
PhosPrint is proud to announce its participation in the EU funded project “UroPrint” under the H2020-FETOPEN-2018-2020 call
PhosPrint is proud to announce its participation in the EU funded project “Tumor-LN-oC” under the H2020 NMBP-23-2020 call
Our co-founder and CTO Ioanna Zergioti was awarded with the 3D printing award at SPIE Photonics West 2020, 3 February in San Francisco as a recognition for the fundamental work in the development of a single step laser bioprinting and immobilization process that offers a significant step towards research of cell properties confined in scaffold environments.
PhosPrint qualifies for the semi-finals of the SPIE Startup Challenge 2020 at the SPIE Photonics West Conference!
PhosPrint receives the Seal of Excellence from the European Commission, for its high-quality project proposal, in a highly competitive evaluation process, submitted under the Horizon 2020 SME Instrument Phase 1 call H2020-EIC-SMEInst-2018-2020 (H2020-SMEInst-2018-2020-1)
Lefkippos Technology Park, NCSR Demokritos
Patriarchou Grigoriou 5’ & Neapoleos 27
153 41, Agia Paraskevh, Athens, Greece
Tax Registration Number: 801099345
General Electronic Commercial Registry (GEMI)